We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov
ClinicalTrials.gov Menu

Erlotinib or Placebo Following Chemoradiotherapy (Chemo/RT) in Stage III Non-Small Cell Lung Cancer (NSCLC)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00153803
Recruitment Status : Completed
First Posted : September 12, 2005
Last Update Posted : November 13, 2014
Sponsor:
Collaborators:
Sanofi
Genentech, Inc.
Information provided by (Responsible Party):
Dartmouth-Hitchcock Medical Center

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Primary Completion Date : April 2014
  Study Completion Date : April 2014